Premium
Indian vaccine producer Biological E is in discussions with global private equity (PE) investors General Atlantic, and TA Associates, among others, to raise up to $250 million by selling a minority stake in the company, two people familiar with the matter said. Biological E, which has a partnership with Johnson & ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
